These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 6809024)

  • 21. Impact of CYP2C9 amino acid polymorphisms on glyburide kinetics and on the insulin and glucose response in healthy volunteers.
    Kirchheiner J; Brockmöller J; Meineke I; Bauer S; Rohde W; Meisel C; Roots I
    Clin Pharmacol Ther; 2002 Apr; 71(4):286-96. PubMed ID: 11956512
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of glimepiride on pancreatic beta-cell function under hyperglycaemic clamp and hyperinsulinaemic, euglycaemic clamp conditions in non-insulin-dependent diabetes mellitus.
    Clark HE; Matthews DR
    Horm Metab Res; 1996 Sep; 28(9):445-50. PubMed ID: 8911981
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Repeated blood glucose and plasma insulin levels in normal volunteer subjects receiving isocaloric meals, before and after chlorpropamide and glibenclamide.
    Owens DR; Seldrup J; Wragg KG; Shetty KJ; Biggs PI
    Horm Metab Res; 1977 Sep; 9(5):347-51. PubMed ID: 411723
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of aspirin and ibuprofen on the pharmacokinetics and pharmacodynamics of glyburide in healthy subjects.
    Kubacka RT; Antal EJ; Juhl RP; Welshman IR
    Ann Pharmacother; 1996 Jan; 30(1):20-6. PubMed ID: 8773160
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The diffusion of pirprofen into the cerebrospinal fluid in man.
    Zecca L; Broggini M; Pirola R; Campi R; Ferrario P; Bichisao E; Maresca V
    Eur J Clin Pharmacol; 1988; 35(1):81-3. PubMed ID: 3220099
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pirprofen. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.
    Todd PA; Beresford R
    Drugs; 1986 Dec; 32(6):509-37. PubMed ID: 3539573
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of glibenclamide on the glucose and insulin profile in maturity onset diabetics following both acute and long term treatment.
    Owens DR; Biggs PI; Shetty KJ; Wragg KG
    Diabete Metab; 1980 Sep; 6(3):219-24. PubMed ID: 6777211
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Pharmacokinetics of pirprofen].
    Hirtz J; Bartlett MF
    Fortschr Med; 1985 Feb; 103(SPEC NO 7A):164-9. PubMed ID: 3872824
    [No Abstract]   [Full Text] [Related]  

  • 29. Inhibition of mitochondrial beta-oxidation of fatty acids by pirprofen. Role in microvesicular steatosis due to this nonsteroidal anti-inflammatory drug.
    Geneve J; Hayat-Bonan B; Labbe G; Degott C; Letteron P; Freneaux E; Dinh TL; Larrey D; Pessayre D
    J Pharmacol Exp Ther; 1987 Sep; 242(3):1133-7. PubMed ID: 3116197
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of combination treatment with acarbose and glibenclamide on postprandial glucose and insulin profiles: additive blood glucose lowering effect and decreased hypoglycaemia.
    Rosak C; Haupt E; Walter T; Werner J
    Diabetes Nutr Metab; 2002 Jun; 15(3):143-51. PubMed ID: 12173728
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effects of magnesium hydroxide on the absorption and efficacy of two glibenclamide preparations.
    Neuvonen PJ; Kivistö KT
    Br J Clin Pharmacol; 1991 Aug; 32(2):215-20. PubMed ID: 1931470
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Pharmacological study of pirprofen].
    Cohen M
    Nouv Presse Med; 1982 Aug; 11(33):2475-80. PubMed ID: 6813822
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Absorption kinetics and model characteristics of orally administered pirprofen.
    Gerardin A; Luders RC; Wagner WE
    J Pharmacokinet Biopharm; 1983 Aug; 11(4):425-33. PubMed ID: 6668551
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A new non-steroidal anti-inflammatory drug pirprofen (rengasil) in the treatment of rheumatoid arthritis and osteoarthrosis].
    Sigidin IaA; Pokryshkin VI
    Ter Arkh; 1987; 59(4):73-6. PubMed ID: 2954253
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics and pharmacological properties of two galenical preparations of glibenclamide, HB419 and HB420, in non insulin-dependent (type 2) diabetes.
    Scheen AJ; Jaminet C; Luyckx AS; Lefebvre PJ
    Int J Clin Pharmacol Ther Toxicol; 1987 Feb; 25(2):70-6. PubMed ID: 3104218
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of multiple oral dosing of nimodipine on glibenclamide pharmacodynamics and pharmacokinetics in elderly patients with type-2 diabetes mellitus.
    Mück W; Heine PR; Breuel HP; Niklaus H; Horkulak J; Ahr G
    Int J Clin Pharmacol Ther; 1995 Feb; 33(2):89-94. PubMed ID: 7757317
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [14C-Glibenclamide concentrations in serum and 14C-glibenclamide urine excretion in diabetic patients with simultaneous determination of blood glucose and insulin (author's transl)].
    Birk W; Schmidt HA; Petrides P
    Arzneimittelforschung; 1978; 28(2):330-7. PubMed ID: 416832
    [No Abstract]   [Full Text] [Related]  

  • 38. Evaluation of BTS 67 582, a novel antidiabetic agent, in normal and diabetic rats.
    Jones RB; Dickinson K; Anthony DM; Marita AR; Kaul CL; Buckett WR
    Br J Pharmacol; 1997 Mar; 120(6):1135-43. PubMed ID: 9134227
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Ankylosing spondylitis. Comparative trial of two non-steroidal anti-inflammatory agents: pirprofen and ketoprofen].
    Renier JC; Fournier M; Loyau G; Roux H
    Nouv Presse Med; 1982 Aug; 11(33):2494-6. PubMed ID: 6752874
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Animal experiments with pirprofen].
    Maier R
    Fortschr Med; 1985 Feb; 103(SPEC NO 7A):159-64. PubMed ID: 3872823
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.